Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.
Methylphenidate can boost joint attention and self-regulation in autistic kids who also have ADHD.
01Research in Context
What this study did
Doctors gave kids with autism and hyperactivity either methylphenidate or a sugar pill. Each child tried both in a crossover design.
The kids were 5 to 13 years old. The team watched joint attention and self-control during each phase.
What they found
Methylphenidate lifted joint attention and self-regulation more than the placebo. The gains were medium-sized, not just calmer bodies.
How this fits with other research
Hara et al. (2016) saw the same drug boost social interaction in autistic mice. Their chronic dosing hints that daily use, not one dose, may matter.
Liu et al. (2022) raised joint attention with ABA instead of pills. Both routes work, so you can pick behavior, medication, or both.
Perez et al. (2015) tested older teens with the same double diagnosis. Stimulants sped their reaction times without harming heart measures, showing safety stretches into adolescence.
Why it matters
You now have evidence that methylphenidate helps core autism skills, not just hyperactivity. If a client with ASD and ADHD struggles to share gaze or stay regulated, talk with the prescriber about a trial. Pair the med with joint-attention ABA for a double punch. Track changes with brief probes so you can adjust dose or teaching in real time.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Run a 5-minute joint-attention probe before the client’s next dose and one hour after; share the data with the prescribing doctor.
02At a glance
03Original abstract
This report examined the effect of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity in a secondary analysis of RUPP Autism Network data. Participants were 33 children (29 boys) between the ages of 5 and 13 years who participated in a four-week crossover trial of placebo and increasing doses of methylphenidate given in random order each for one week. Observational measures of certain aspects of children's social communication, self-regulation, and affective behavior were obtained each week. A significant positive effect of methylphenidate was seen on children's use of joint attention initiations, response to bids for joint attention, self-regulation, and regulated affective state. The results go beyond the recent literature and suggest that methylphenidate may have positive effects on social behaviors in children with PDD and hyperactivity.
Journal of autism and developmental disorders, 2009 · doi:10.1007/s10803-008-0636-9